Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CMV
CMV
FDA approves Merck's letermovir to prevent CMV in kidney transplant recipients
FDA approves Merck's letermovir to prevent CMV in kidney transplant recipients
Healio
Merck
FDA
letermovir
CMV
kidney transplants
Prevymis
Flag link:
Where Will Moderna Be in 1 Year?
Where Will Moderna Be in 1 Year?
Motley Fool
Moderna Therapeutics
MRNA
vaccines
COVID-19
RSV
CMV
Flag link:
Hookipa halts spending on cytomegalovirus vaccine after seeing phase 2 data
Hookipa halts spending on cytomegalovirus vaccine after seeing phase 2 data
Fierce Biotech
Hookipa
CMV
vaccines
HB-101
kidney transplants
Flag link:
Merck seeks more approvals for infectious disease drug
Merck seeks more approvals for infectious disease drug
Endpoints
Merck
CMV
FDA
Prevymis
Flag link:
Merck tees up Prevymis filing in kidney transplant recipients after phase 3 trial win
Merck tees up Prevymis filing in kidney transplant recipients after phase 3 trial win
Fierce Pharma
Merck
Prevymis
kidney transplants
clinical trials
CMV
IDWeek
Flag link:
FDA offers support for Takeda's potential cytomegalovirus drug ahead of adcomm
FDA offers support for Takeda's potential cytomegalovirus drug ahead of adcomm
Endpoints
Takeda
FDA
CMV
post-transplant cytomegalovirus
Shire
maribavir
Flag link:
FDA Accepts NDA for Takeda’s Maribavir
FDA Accepts NDA for Takeda’s Maribavir
BioSpace
Takeda
post-transplant cytomegalovirus
CMV
maribavir
FDA
Flag link:
Takeda tees up priority review for storied CMV drug from its $62B Shire buyout
Takeda tees up priority review for storied CMV drug from its $62B Shire buyout
Endpoints
Shire
Takeda
M&A
CMV
maribavir
Flag link:
Here Are the Most Exciting Vaccines in Moderna's Pipeline
Here Are the Most Exciting Vaccines in Moderna's Pipeline
Motley Fool
Moderna Therapeutics
vaccines
cancer vaccines
COVID-19
CMV
Flag link:
Takeda's maribavir clears cytomegalovirus infections in phase 3
Takeda's maribavir clears cytomegalovirus infections in phase 3
Fierce Biotech
Takeda
clinical trials
maribavir
CMV
Flag link:
Meet Moderna's Most Likely Blockbusters After Its COVID Vaccine
Meet Moderna's Most Likely Blockbusters After Its COVID Vaccine
Motley Fool
Moderna Therapeutics
CMV
cytomegalovirus
mRNA-1647
Flag link:
Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks
Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks
Fierce Biotech
Takeda
TAK-620
clinical trials
CMV
Flag link:
Moderna, though early in development, prepares its vaccine for market
Moderna, though early in development, prepares its vaccine for market
BioPharma Dive
Moderna Therapeutics
CMV
vaccines
Flag link:
Astellas, Vical's CMV vaccine comes up short in Phase 3
Astellas, Vical's CMV vaccine comes up short in Phase 3
Biopharma Dive
Astellas
Vical
CMV
cytomegalovirus
vaccines
clinical trials
ASP0113
Flag link:
Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Endpoints
Merck
FDA
CMV
Prevymis
AiCuris
Flag link:
Merck tees up US/European applications for letermovir after detailing PhIII antiviral success
Merck tees up US/European applications for letermovir after detailing PhIII antiviral success
Endpoints
Merck
Europe
letermovir
clinical trials
CMV
Flag link:
VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate
VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate
Yahoo
VBI Vaccines
clinical trials
vaccines
CMV
cytomegalovirus
Flag link:
Chimerix scraps two PhIII trials as it regroups in wake of a setback
Chimerix scraps two PhIII trials as it regroups in wake of a setback
Fierce Biotech
Chimerix
clinical trials
Brincidofovir
CMV
antivirals
Flag link:
Merck, AiCuris announce publication of letermovir Phase 2 trial results
Merck, AiCuris announce publication of letermovir Phase 2 trial results
The Fly on the Wall
AiCuris
Merck
letermovir
CMV
Flag link:
Astellas/Vical Start TransVax Phase III Study
Astellas/Vical Start TransVax Phase III Study
Yahoo/Zacks
CMV
cytomegalovirus
TransVax
clinical trials
Astellas
vaccines
Vical
Flag link:
Pages
1
2
next ›
last »